MX2008010037A - Uso de polvo de soya kefir para reducir dolor, presion sanguinea e inflamacion. - Google Patents

Uso de polvo de soya kefir para reducir dolor, presion sanguinea e inflamacion.

Info

Publication number
MX2008010037A
MX2008010037A MX2008010037A MX2008010037A MX2008010037A MX 2008010037 A MX2008010037 A MX 2008010037A MX 2008010037 A MX2008010037 A MX 2008010037A MX 2008010037 A MX2008010037 A MX 2008010037A MX 2008010037 A MX2008010037 A MX 2008010037A
Authority
MX
Mexico
Prior art keywords
blood pressure
inflammation
soy
kefir powder
soy kefir
Prior art date
Application number
MX2008010037A
Other languages
English (en)
Inventor
Stan Kubow
John Sheppard
Original Assignee
Kclm Res In Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kclm Res In Nutrition Inc filed Critical Kclm Res In Nutrition Inc
Publication of MX2008010037A publication Critical patent/MX2008010037A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/155—Kefiri
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/31—Leuconostoc
    • A23V2400/321—Mesenteroides

Abstract

La presente invención se refiere a un polvo de soya Kéfir producido a través de la fermentación de leche de soya con granos de Kéfir de la cepa de Moscú bajo condiciones de fermentación adecuadas. El polvo de soya Kéfir de la invención tiene por lo menos una de las siguientes actividades biológicas: alivia el dolor, reduce presión sanguínea y reduce inflamación. La presente invención también se refiere al método para la producción del polvo de soya Kéfir de la invención. También se refiere al uso del polvo de soya Kéfir de la invención para aliviar dolor, reducir presión sanguínea y reducir inflamación. La invención también se refiere a métodos para aliviar dolor, reducir presión sanguínea y reducir inflamación utilizando el polvo de soya Kéfir de la invención.
MX2008010037A 2006-02-02 2007-02-02 Uso de polvo de soya kefir para reducir dolor, presion sanguinea e inflamacion. MX2008010037A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76437206P 2006-02-02 2006-02-02
PCT/CA2007/000152 WO2007087722A1 (en) 2006-02-02 2007-02-02 Use of soy kefir powder for reducing pain, blood pressure and inflammation

Publications (1)

Publication Number Publication Date
MX2008010037A true MX2008010037A (es) 2009-01-15

Family

ID=38327112

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008010037A MX2008010037A (es) 2006-02-02 2007-02-02 Uso de polvo de soya kefir para reducir dolor, presion sanguinea e inflamacion.

Country Status (3)

Country Link
US (1) US20090221469A1 (es)
MX (1) MX2008010037A (es)
WO (1) WO2007087722A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090196867A1 (en) * 2007-11-26 2009-08-06 Kclm Research In Nutrition Inc. Soy kefir powder and uses thereof
EP2569415A4 (en) * 2010-05-14 2015-04-22 Lactoscience Inc PROCESS FOR FERMENTATION OF A MIXED CULTURE SUBSTRATE FOR PRODUCING ANIMAL-REPRODUCIBLE BIOMASS AND / OR READY FOR MANUAL CONSUMPTION
CN105942471A (zh) * 2016-06-03 2016-09-21 安阳市京膳堂饮料有限公司 一种开菲尔发酵的坚果酱和/或谷物酱和植物蛋白果蔬复合饮料及其制备方法
WO2020176985A1 (en) * 2019-03-04 2020-09-10 The Governors Of The University Of Alberta Method for the production of traditional kefir

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417687A1 (en) * 2000-06-22 2001-12-27 Mcgill University Kefir as a potent anti-oxidant composition
JP2003310154A (ja) * 2002-04-19 2003-11-05 Nippon Kefia Kk ケフィアグレインを用いた豆乳の発酵方法及び発酵産物
JP2005312424A (ja) * 2004-04-30 2005-11-10 Nippon Kefia Kk ケフィアグレインを用いた発酵産物の製造方法及び当該方法によって得られる発酵産物
JP3935490B2 (ja) * 2005-12-09 2007-06-20 日本ケフィア株式会社 豆乳ケフィア及びその製造方法

Also Published As

Publication number Publication date
WO2007087722A1 (en) 2007-08-09
US20090221469A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
MX2010005643A (es) Preparados, metodos y estuches utiles para el tratamiento de la tos.
MX2011007966A (es) Sistema y metodo para hipertension.
WO2010085795A3 (en) Novel pasteuria strain
AU2011372711B2 (en) Method for processing mesenchymal stem cells and the use thereof in the treatment of diseases associated with oxidative stress
MX2010007490A (es) Preparacion de derivados de sulfamida.
HK1159486A1 (en) Cosmetic composition for anti-aging of the skin comprising phaseolus radiatus seed extracts by fermentation and enzyme treatment
WO2006048242A3 (en) Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
EP2452673A4 (en) CHITOSAN GEL FOR DERMATOLOGICAL APPLICATIONS, METHOD FOR OBTAINING AND USING THE SAME
WO2007127791A3 (en) New pharmacological method for treatment of neuropathic pain
MX2009006672A (es) Efectos combinados de topiramato y ondansetron sobre el consumo de alcohol.
MY170934A (en) Treatment of pain associated with dislocation of basal endometrium
MY159244A (en) Method of reducing intraocular pressure in humans
WO2011016861A3 (en) Novel regulatory proteins and inhibitors
WO2009008656A3 (en) A soap composition for atopic dermatitis containing fermented extract of xanthium strumarium l. and preparation method thereof
MX2008010037A (es) Uso de polvo de soya kefir para reducir dolor, presion sanguinea e inflamacion.
EP2332928A3 (en) Method for lysing cellulose
WO2011031145A3 (en) Improved soy milk fermentation
WO2014018549A3 (en) Systems and methods for treatment of androgenetic skin conditions by microbial organisms
AU2011343331A8 (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
WO2011009987A3 (es) Derivados de ácidos aureólicos, su procedimiento de obtención y sus usos
WO2012040444A3 (en) Treatment of patients with incipient alzheimer's disease
WO2011050099A3 (en) Therapeutic composition
WO2012057417A8 (ko) 홍어 추출물을 함유하는 조성물
WO2009036753A3 (de) Neue pharmazeutika, verfahren zu ihrer herstellung und ihre verwendung in der medizinischen therapie
MX2010000823A (es) Metodo para eliminar enfermedades de plantas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal